Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Intro slide
- The biological issue: differential mRNA turnover
- Decay rates of mammalian mRNA
- mRNA decay as a control in gene expression
- mRNA decay role in limiting viruses
- mRNAs protective modifications
- General pathways of mRNA turnover
- Specialized pathways of mRNA turnover
- Targeting of nucleases to specific mRNA
- Regulation of endonuclease cleavage
- Individual steps as regulators of decay rate
- Stability elements as a regulators of decay rates
- Proteins as a regulators of mRNA degradation
- Co-regulation of proteins of related functions
- miRNA as a regulator of mRNA turnover
- mRNA stability: more regulators
- Examples of mRNA stability regulation
- Summary of stability elements
- Nucleases of mRNA turnover
- mRNA deadenylases
- Ccr4/Pop2/NOT complex
- Pan2/Pan3 complex and PARN
- Substrate preferences of different deadenylases
- Implication (1)
- Implication (2)
- 3' to 5' exonucleolytic decay
- Exosome functions
- Exosome organization
- An archeal exosome
- Rrp6 association with the exosome
- Co-factors of exosome in mRNA degradation
- Exosome recruitment to the substrate
- Decapping of the final product
- DcpS decapping enzyme
- 5' to 3' exonucleolytic decay
- Decapping as a control for mRNA decay
- Dcp1p/Dcp2p decapping enzyme
- Assembly of mRNA decapping complex
- Translation and decapping as a distinct states
- P-bodies and their content (1)
- P-bodies and their content (2)
- P-bodies as sites of decapping
- mRNA cycle
- Mechanism for translation repression
- Stress granules
- Biochemical states of cytoplasmic mRNA
- P-bodies as translation repressor
- Regulators of the translation status
- miRNAs target mRNAs to P-bodies
- The mRNA decay network
- Sites of quality control in mRNA turnover
- Quality control in the nucleus
- Quality control in the cytoplasm (nonstop decay)
- The C-terminal domain of ski7p
- Molecular mimicry?
- Nonstop decay
- Premature polyadenylation
- Nonsense-mediated decay
- Factors of nonsense-mediated decay
- Affects of nonsense-mediated decay on turnover
- Upf1p in the decay of "normal" RNA
- Aberrant and normal RNA: model in yeast
- Aberrant and normal RNA: model in mammals
- Present knowledge
- References (1)
- References (2)
- References (3)
Topics Covered
- Control of mRNA degradation
- Modulation in response to physiological cues
- Mechanisms of mRNA turnover
- Critical nucleases
- Sequence-specific binding of regulators
- Rates of turnover
- mRNA decay and viral infections
- Role in recognizing aberrant mRNAs
Talk Citation
Parker, R. (2007, October 1). The mechanisms and control of mRNA turnover in eukaryotic cells [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/ZKFD7065.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Roy Parker has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.